Advertisement
News
Subscribe to MDT Magazine News

Blood Test Identifies Heart-Transplant Rejection Earlier than Biopsy Can

July 14, 2014 1:27 pm | by Stanford University | Comments

Stanford University researchers have devised a noninvasive way to detect heart-transplant rejection weeks or months earlier than previously possible. The test, which relies on the detection of increasing amounts of the donor’s DNA in the blood...

TOPICS:

Photos of the Day: Squishy Surgical Robots

July 14, 2014 12:12 pm | by MIT | Comments

Working with robotics company Boston Dynamics, the researchers began developing the material as part of the Chemical Robots program of the Defense Advanced Research Projects Agency (DARPA). The agency was interested in “squishy” robots...

TOPICS:

Phase-Changing Material to Allow Robots to Switch Between Hard and Soft States

July 14, 2014 12:10 pm | by Helen Knight, MIT News correspondent | Comments

In the movie “Terminator 2,” the shape-shifting T-1000 robot morphs into a liquid state to squeeze through tight spaces or to repair itself when harmed. Now a phase-changing material built from wax and foam, and capable of switching between...

TOPICS:
Advertisement

3D Printed Anatomy to Mark New Era for Medical Training

July 14, 2014 11:06 am | by Monash University | Comments

The creators of a unique kit containing anatomical body parts produced by 3D printing say it will revolutionize medical education and training, especially in countries where cadaver use is problematical. The '3D Printed Anatomy Series...  

TOPICS:

Study of Noninvasive Retinal Imaging Device Presented at Alzheimer's Conference

July 14, 2014 10:27 am | by Cedars-Sinai Medical Center | Comments

A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease, according to preliminary results from investigators conducting...

TOPICS:

Smell and Eye Tests Show Potential to Detect Alzheimer's Early

July 14, 2014 10:23 am | by Alzheimer's Association | Comments

A decreased ability to identify odors might indicate the development of cognitive impairment and Alzheimer's disease, while examinations of the eye could indicate the build-up of beta-amyloid, a protein associated with Alzheimer's, in the brain...

TOPICS:

Researchers Invent Nanotech Microchip to Diagnose Type-1 Diabetes

July 14, 2014 10:17 am | by Stanford University Medical Center | Comments

An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School...

TOPICS:

Scientists Find Genetic Recipe to Turn Stem Cells into Blood

July 14, 2014 10:08 am | by University of Wisconsin-Madison | Comments

The ability to reliably and safely make in the laboratory all of the different types of cells in human blood is one key step closer to reality. Writing today in the journal Nature Communications, a group led by University of Wisconsin-Madison...

TOPICS:
Advertisement

New Technology Developed to Diagnose Cancer Cells

July 14, 2014 9:48 am | by Medical University of Vienna | Comments

In pathology, cells and cell nuclei are usually examined using a microscope for bio-marker expressions in tumors. This analysis is used to weigh up the treatment options for patients who have cancer, for example. The certainty of the diagnosis...

TOPICS:

Boston Scientific Receives CE Mark for Ranger Drug-Coated Balloon

July 14, 2014 9:31 am | by PR Newswire | Comments

Demonstrating its continued leadership in the development of innovative solutions for peripheral vascular disease, Boston Scientific Corporation has received CE Mark for the Ranger Paclitaxel-Coated PTA Balloon Catheter. The technology is...

TOPICS:

St. Jude Medical Announces Definitive Agreement to Acquire NeuroTherm

July 14, 2014 9:24 am | by Business Wire | Comments

St. Jude Medical, a global medical device company, today announced that it has signed a definitive agreement to acquire privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies, for approximately $200 million...

TOPICS:

FDA Weighs Cancer Risk of Fibroid Removal Devices

July 14, 2014 9:18 am | by Matthew Perrone - AP Health Writer | Comments

Federal health advisers say there is little to no evidence that a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body. The panel of Food and Drug Administration...

TOPICS:

Titan Spine Receives FDA Clearance to Launch Endoskeleton TL Device for Lateral Spinal Fusion

July 14, 2014 9:16 am | by The Associated Press | Comments

Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to commercially release...

TOPICS:

FDA Approval of IDE for VENITI VICI Venous Stent System

July 14, 2014 9:16 am | by PR Newswire | Comments

VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption...

TOPICS:

Better Use of Electronic Health Records Makes Clinical Trials Less Expensive

July 11, 2014 3:07 pm | by University of Manchester | Comments

Using electronic health records to understand the best available treatment for patients, from a range of possible options, is more efficient and less costly for taxpayers than the existing clinical trial process, a new study shows. Research...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading